Search

Your search keyword '"Timms K"' showing total 171 results

Search Constraints

Start Over You searched for: Author "Timms K" Remove constraint Author: "Timms K"
171 results on '"Timms K"'

Search Results

2. TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker

6. Consensus on current management of endometriosis

8. Design and experimental results of the Nb3Sn double insert for an 18 Tesla, 100 mm free bore solenoid

9. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

10. Fabrication of high Tc coils from BSCCO 2212 powder in tube and dip coated tape

14. Analysis of BRCA genes and homologous recombination deficiency (HRD) scores in tumours from patients (pts) with metastatic breast cancer (mBC) in the OlympiAD trial

16. Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto

17. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

18. Homologous repair deficiency (HRD) as measure to predict the effect of carboplatin on survival in the neoadjuvant phase II trial GeparSixto in triple-negative early breast cancer

19. Breast cancer brain metastases show increased levels of genomic aberration based homologous recombination deficiency scores relative to their corresponding primary tumors

20. Homologous repair deficiency (HRD) as measure to predict the effect of carboplatin on survival in the neoadjuvant phase II trial GeparSixto in triple-negative early breast cancer

21. Abstract P1-09-02: Homologous repair deficiency (HRD) as measure to predict the effect of carboplatin on survival in the neoadjuvant phase II trial GeparSixto in triple-negative early breast cancer

22. Abstract P6-09-09: Evaluation of tumor infiltrating lymphocytes (TILs) and their association with homologous recombination deficiency and BRCA1/2 mutation status in triple-negative breast cancer (TNBC): A pooled analysis

23. P1.03Analysis of Biomarkers and PK Modeling of ABT-767 in Patients With BRCA1/BRCA2-Mutated Tumors or High Grade Serous Ovarian Cancer

26. 3-biomarker HRD score versus individual biomarker (LOH, TAI, LST) scores in platinum treated serous ovarian cancer (SOC)

29. Abstract P3-07-13: Homologous recombination deficiency (HRD) as a predictive biomarker of response to preoperative systemic therapy (PST) in TBCRC008 comprising a platinum in HER2-negative primary operable breast cancer

30. Abstract P3-07-12: Homologous recombination deficiency (HRD) as a predictive biomarker of response to neoadjuvant platinum-based therapy in patients with triple negative breast cancer (TNBC): A pooled analysis

31. Abstract P3-07-29: Role of germline BRCA status and tumor homologous recombination (HR) deficiency in response to neoadjuvant weekly paclitaxel followed by anthracycline-based chemotherapy

32. 466 Next generation sequencing of BRCA1 and BRCA2 genes in ovarian tumors captures all germline mutations and expands the potential treatment group for the PARP inhibitor olaparib

34. 435 Candidate biomarkers of PARP inhibitor sensitivity in ovarian cancer beyond the BRCA genes

36. Next Generation Sequencing of Brca1/2 in High Grade Ovarian Tumors Expands Brca Defects Beyond Germline Mutations

39. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer

43. Somatic BRCA status in ovarian tumors

44. 17 GENOME-WIDE ASSOCIATION SCAN OF OSTEOARTHRITIS OF THE KNEE

46. Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis

Catalog

Books, media, physical & digital resources